HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kai-Wen Hsu Selected Research

Notch1 Receptor

6/2016Notch1 pathway-mediated microRNA-151-5p promotes gastric cancer progression.
12/2012Notch2-induced COX-2 expression enhancing gastric cancer progression.
8/2012Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression.
6/2009The activated Notch1 signal pathway is associated with gastric cancer progression through cyclooxygenase-2.
8/2008The activated Notch1 receptor cooperates with alpha-enolase and MBP-1 in modulating c-myc activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kai-Wen Hsu Research Topics

Disease

21Neoplasms (Cancer)
05/2022 - 06/2009
13Neoplasm Metastasis (Metastasis)
05/2022 - 01/2016
7Stomach Neoplasms (Stomach Cancer)
04/2020 - 06/2009
6Breast Neoplasms (Breast Cancer)
01/2022 - 01/2016
6Carcinogenesis
01/2021 - 08/2008
4Hypoxia (Hypoxemia)
10/2021 - 01/2020
3Thyroid Neoplasms (Thyroid Cancer)
01/2022 - 01/2019
3Triple Negative Breast Neoplasms
01/2021 - 01/2017
3Adenocarcinoma
12/2012 - 06/2009
2Leukemia
05/2020 - 01/2020
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2020 - 05/2019
1Disseminated Intravascular Coagulation
01/2022
1Pancreatitis
01/2022
1Adenocarcinoma of Lung
09/2021
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2021
1Uterine Cervical Neoplasms (Cancer of the Cervix)
12/2020
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2020
1Philadelphia Chromosome
05/2020
1Blast Crisis (Blast Phase)
05/2019
1Chronic Disease (Chronic Diseases)
05/2019
1Anaplastic Thyroid Carcinoma
01/2018
1Acute Erythroblastic Leukemia (Erythroleukemia)
08/2012

Drug/Important Bio-Agent (IBA)

5MicroRNAs (MicroRNA)IBA
09/2021 - 01/2014
5Notch1 ReceptorIBA
06/2016 - 08/2008
4Proteins (Proteins, Gene)FDA Link
05/2022 - 07/2014
4Estrogen ReceptorsIBA
01/2022 - 02/2018
3Histones (Histone)IBA
01/2022 - 02/2018
3Pharmaceutical PreparationsIBA
01/2022 - 06/2017
3Long Noncoding RNAIBA
10/2021 - 01/2020
2Lysine (L-Lysine)FDA Link
01/2022 - 01/2021
2ChromatinIBA
10/2021 - 01/2021
2RNA (Ribonucleic Acid)IBA
09/2021 - 01/2021
2LuteolinIBA
01/2021 - 01/2020
2human ERBB2 proteinIBA
01/2021 - 02/2018
2Progesterone Receptors (Progesterone Receptor)IBA
01/2021 - 02/2018
2PanobinostatIBA
01/2019 - 02/2018
2Transcription Factors (Transcription Factor)IBA
07/2014 - 08/2012
2Phosphopyruvate Hydratase (Enolase)IBA
01/2014 - 08/2008
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
12/2012 - 06/2009
2LigandsIBA
08/2012 - 06/2009
1Tyrosine (L-Tyrosine)FDA Link
05/2022
1Proliferating Cell Nuclear Antigen (PCNA)IBA
05/2022
1nafamostatIBA
01/2022
1Sunitinib (Sutent)FDA Link
01/2022
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022
1Therapeutic UsesIBA
09/2021
1Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
09/2021
1Androgen Receptors (Androgen Receptor)IBA
01/2021
1MucinsIBA
10/2020
1GemcitabineFDA Link
10/2020
1NucleosidesIBA
10/2020
1A 7 (A-7)IBA
10/2020
1Interleukin-17 ReceptorsIBA
10/2020
1Oncogene Proteins (Oncogene Protein)IBA
05/2020
13-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA
04/2020
1Dipyridamole (Persantine)FDA LinkGeneric
04/2020
1EnzymesIBA
04/2020
1Mevalonic Acid (Mevalonate)IBA
04/2020
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2020
1Hormones (Hormone)IBA
01/2020
1MTOR InhibitorsIBA
01/2020
1TamoxifenFDA LinkGeneric
01/2020
1Mitochondrial DNA (mtDNA)IBA
01/2020
1bcr-abl Fusion ProteinsIBA
05/2019
1Imatinib Mesylate (Gleevec)FDA Link
05/2019
1Histone Deacetylase InhibitorsIBA
01/2019
1belinostatIBA
02/2018
1Doxorubicin (Adriamycin)FDA LinkGeneric
02/2018
1AfatinibIBA
01/2018
1ErbB Receptors (EGF Receptor)IBA
01/2018
1LuciferasesIBA
06/2017
1Biomarkers (Surrogate Marker)IBA
01/2017
1Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA
01/2017
1Messenger RNA (mRNA)IBA
06/2016
1Focal Adhesion Protein-Tyrosine KinasesIBA
06/2016
1Basic Helix-Loop-Helix Transcription FactorsIBA
01/2016
1Cadherins (E-Cadherin)IBA
01/2016
13' Untranslated Regions (3' UTR)IBA
01/2016
1Notch ReceptorsIBA
12/2012
1Notch2 ReceptorIBA
12/2012
1Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA
12/2012
1N- (2- cyclohexyloxy- 4- nitrophenyl)methanesulfonamideIBA
12/2012
1Prostaglandins EIBA
12/2012
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
08/2012
1Carrier Proteins (Binding Protein)IBA
12/2009

Therapy/Procedure

7Therapeutics
01/2022 - 08/2012
3Drug Therapy (Chemotherapy)
01/2021 - 01/2020
1Transplantation
06/2017